MENU
DMAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
DiaMedica Therapeutics (DMAC) Ownership - Who owns DiaMedica Therapeutics?
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
19
Web
https://www.diamedica.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
166.28M
P/E Ratio
N/A
Total Cash
50.2M
Projected Growth
N/A
Total Debt
365K
Revenue
N/A
Risk (Beta)
1.17
Dividend Yield
N/A
Total Cash/Share
1.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
DMAC
Capitalization
166M
P/E Ratio
N/A
Risk (Beta)
1.17
Dividend Yield
N/A
Total Cash
50.2M
Total Cash/Share
1.17
Total Debt
365K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
48M
P/B Ratio
4.17
Cash Flow
N/A
Earnings
-0.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
11.81
Current Revenue Per Employee
45787.00
Dividends Per Share - Security
N/A
EBITDA
-24.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-39.23
Shares Held By Institutions
43.5M
Shares Outstanding - Current
42.9M
Total Liabilities
4.56M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-27.072
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel therapeutic compounds for diabetes and other diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
19
Web
https://www.diamedica.com